This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.
S. Albert , K. Marder , G. Dooneief , K. Bell , M. Sano , Y. Stern (1995). Neuropsychologic impairment in early HIV infection: A risk for work disability. Archives of Neurology, 52, 525–530.
S. Albert , C.M. Weber , G. Todak , C. Polanco , R. Clouse , M. McElhiney , K. Marder (1999). An observed performance test of medication management ability in HIV: Relation to neuropsychological status and medication outcomes. AIDS and Behavior, 3, 121–128.
A. Antinori , G. Arendt , J.T. Becker , B.J. Brew , D.A. Byrd , M. Cherner , V.E. Wojna (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69(18), 1789–1799.
A.T. Beck , R.A. Steer , G.K. Brown (1996). Beck Depression Inventory-Second Edition Manual. San Antonio, TX: The Psychological Corporation.
R.H.B. Benedict , J.J. Mezhir , K. Walsh , R.G. Hewitt (2000). Impact of human immunodeficiety virus type-1-associated cognitive dysfunction on activities of daily living and quality of life. Archives of Clinical Neuropsychology, 15, 535–544.
M.A. Chesney , J.R. Ickovics , D.B. Chambers , A.L. Gifford , J. Neidig , B. Zwickl , A. Wu (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS Care, 12(3), 255–266.
L.A. Cysique , S.L. Letendre , C. Ake , H. Jin , D.R. Franklin , S. Gupta , R.L. Heaton , for the HIV Neurobehavioral Research Center group. (2011). Incidence and nature of cognitive decline over 1 year among HIV-infected former plasma donors in China. AIDS, 24(7), 983–990.
R.K. Heaton , D.B. Clifford , D.R. Franklin Jr., S.P. Woods , C. Ake , F. Vaida , I. Grant , for the CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study. Neurology, 75(23), 2087–2096.
R.K. Heaton , T.D. Marcotte , D.A. White , D. Ross , K. Meredith , M.J. Taylor , I. Grant (1996). Nature and vocational significance of neuropsychological impairment associated with HIV infection. The Clinical Neuropsychologist, 10(1), 1–14.
R.K. Heaton , M.J. Taylor , J. Manly , D.S. Tulsky (2003). Demographic effects and use of demographically corrected norms with the WAIS-III and WMS-III. In Clinical interpretation of the WAIS-III and WMS-III (pp. 181–210). Burlington: Academic Press.
C.H. Hinkin , S.A. Castellon , R.S. Durvasula , D.J. Hardy , M.N. Lam , K.I. Mason , M. Stefaniak (2002). Medication adherence among HIV+ adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59(12), 1944–1950.
J. Hunsley , G.J. Meyer (2003). The incremental validity of psychological testing and assessment: Conceptual, methodological, and statistical issues. Psychological Assessment, 15(4), 446–455.
J.A. Joska , J. Westgarth-Taylor , L. Myer , J. Hoare , K.G.F. Thomas , M. Combrinck , A.J. Flisher (2011). Characterization of HIV-associated neurocognitive disorders among individuals starting antiretroviral therapy in South Africa. AIDS Behavior, 15, 1197–1203.
M. Lu , S.A. Safren , P.R. Skolnik , W.H. Rogers , W. Coady , H. Hardy , I.B. Wilson (2008). Optimal recall period and response task for self-reported HIV medication adherence. AIDS Behavior, 12(1), 86–94.
G.J. Meyer , S.E. Finn , L.D. Eyde , G.G. Kay , K.L. Moreland , R.R. Dies , G.M. Reed (2001). Psychological testing and psychological assessment. A review of evidence and issues. The American Psychologist, 56(2), 128–165.
D.J. Moore , B.W. Palmer , T.L. Patterson , D.V. Jeste (2007). A review of performance-based measures of functional living skills. Journal of Psychiatric Research, 41(1-2), 97–118.
S.B. Rourke , M.H. Halman , C. Bassel (1999). Neurocognitive complaints in HIV-infection and their relationship to depressive symptoms and neuropsychological functioning. Journal of Clinical and Experimental Neuropsychology, 21(6), 737–756.
C.E. Schwartz , E. Kozora , Q. Zeng (1996). Towards patient collaboration in cognitive assessment: Specificity, sensitivity, and incremental validity of self-report. Annals of Behavioral Medicine, 18(2), 177–184.
J.M. Simoni , A.E. Kurth , C.R. Pearson , D.W. Pantalone , J.O. Merrill , P.A. Frick (2006). Self-report measures of antiretroviral therapy adherence: A review with recommendations for HIV research and clinical management. AIDS Behavior, 10(3), 227–245.
A.D. Thames , B.W. Becker , T.D. Marcotte , L.J. Hines , J.M. Foley , A. Ramezani , C.H. Hinkin (2010). Depression, cognition, and self-appraisal of functional abilities in HIV: An examination of subjective appraisal versus objective performance. The Clinical Neuropsychologist, 25, 224–243.
A.D. Thames , M.S. Kim , B.W. Becker , J.M. Foley , L.J. Hines , E.J. Singer , C.H. Hinkin (2010). Medication and finance management among HIV-infected adults: The impact of age and cognition. Journal of Clinical Experimental Neuropsychology, 33, 200–209.
E.W. Twamley , J.M. Naraez , J.R. Sadek , D.V. Jeste , I. Grant , R.K. Heaton (2006). Work-related abilities in schizophrenia and HIV infection. Journal of Nervous and Mental Disease, 194, 268–274.
Valpar International Corporation. (1986). Microcomputer Evaluation and Screening Assessment (MESA) Short Form 2. Tucson, AZ.
Valpar International Corporation. (1992). Computerized Assessment (COMPASS). Tuscon, AZ: Valpar Corporation.
G. Wagner , L.G. Miller (2004). Is the influence of social desirability on patients’ self-reported adherence overrated? Journal of Acquired Immune Deficiency Syndromes, 35(2), 203–204.
S.P. Woods , D.J. Moore , E. Weber , I. Grant (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychological Review, 10, 152–168.
S.P. Woods , J.D. Rippeth , A.B. Frol , J.K. Levy , E. Ryan , V.M. Soukup , R.K. Heaton (2004). Interrater reliability of clinical ratings and neurocognitive diagnoses in HIV. Journal of Clinical Experimental Neuropsychology, 26(6), 759–778.
World Health Organization. (1997). Composite international diagnostic interview, version 2.1. Geneva: WHO.
R.K. Heaton , D.R. Franklin , R.J. Ellis , J.A. McCutchan , S.L. Letendre , I. Grant (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17(1), 3–16.